SBS owns the FDA approved SBS 1615 catalytic oxygen generator and associated systems. The generator provides medical grade USP oxygen at the push of a button from self-contained inert dry compounds.
SBS intends to make the portable, small personal life-saving device become as common in everyday life as household fire extinguishers, smoke detectors and first-aid kits. The term sheet is pursuant to an option between the two companies that was executed and reported on May 10th.
SBS’ research leads the company to believe that the critical-need domestic market could translate into a multibillion dollar business.
The first of several oxygen delivery systems using the SBS 1615 catalytic oxygen generator is called LifedGE, which is scheduled for pilot scale production. LifedGE is a lightweight, on demand dispenser of emergency-duration medical grade oxygen, created by the SBS 1615 catalytic oxygen generator.
The companies said that there is no other technologically equivalent product available currently. The LifedGE prototype is trademarked and protected by multiple patents.
Another Stand-By Systems product for use with the SBS 1615 catalytic oxygen generator is the MayDay, which is an emergency personnel escape system (self-contained breathing apparatus).
The MayDay is expected to replace technologically obsolete devices currently deployed within the military, in sensitive governmental installations and in industrial plants.
Emerging Healthcare Solutions focuses on the development of profitable emerging medical technology, a sector that also includes Johnson & Johnson, Human Genome Sciences, Novartis and GlaxoSmithKline.
